Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""recurrence"" wg kryterium: Temat


Tytuł :
Transcatheter arterial chemoembolization alone or combined with ablation for recurrent intermediate-stage hepatocellular carcinoma: a propensity score matching study.
Autorzy :
Wang C; State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, 651 Dongfeng Road East, Guangzhou, 510060, China.; Department of Hepatobiliary Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China.
Liao Y; State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, 651 Dongfeng Road East, Guangzhou, 510060, China.; Department of Hepatobiliary Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China.
Qiu J; State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, 651 Dongfeng Road East, Guangzhou, 510060, China.; Department of Hepatobiliary Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China.
Yuan Y; State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, 651 Dongfeng Road East, Guangzhou, 510060, China.; Department of Hepatobiliary Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China.
Zhang Y; State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, 651 Dongfeng Road East, Guangzhou, 510060, China.; Department of Hepatobiliary Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China.
Li K; State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, 651 Dongfeng Road East, Guangzhou, 510060, China.; Department of Hepatobiliary Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China.
Zou R; State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, 651 Dongfeng Road East, Guangzhou, 510060, China.; Department of Ultrasound, Sun Yat-Sen University Cancer Center, Guangzhou, China.
Wang Y; State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, 651 Dongfeng Road East, Guangzhou, 510060, China.; Department of Hepatobiliary Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China.
Zuo D; State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, 651 Dongfeng Road East, Guangzhou, 510060, China.
He W; State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, 651 Dongfeng Road East, Guangzhou, 510060, China.; Department of Hepatobiliary Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China.
Zheng Y; State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, 651 Dongfeng Road East, Guangzhou, 510060, China.; Department of Hepatobiliary Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China.
Li B; State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, 651 Dongfeng Road East, Guangzhou, 510060, China. .; Department of Hepatobiliary Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China. .
Yuan Y; State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, 651 Dongfeng Road East, Guangzhou, 510060, China. .; Department of Hepatobiliary Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China. .
Pokaż więcej
Źródło :
Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2020 Oct; Vol. 146 (10), pp. 2669-2680. Date of Electronic Publication: 2020 May 25.
Typ publikacji :
Journal Article
MeSH Terms :
Carcinoma, Hepatocellular/*therapy
Chemoembolization, Therapeutic/*methods
Liver Neoplasms/*therapy
Neoplasm Recurrence, Local/*therapy
Radiofrequency Ablation/*methods
Adult ; Carcinoma, Hepatocellular/pathology ; Cohort Studies ; Female ; Humans ; Liver Neoplasms/pathology ; Male ; Microwaves/therapeutic use ; Middle Aged ; Neoplasm Recurrence, Local/pathology ; Neoplasm Staging ; Prognosis ; Progression-Free Survival ; Propensity Score ; Retrospective Studies ; Survival Rate
Czasopismo naukowe
Tytuł :
ΔNp63 transcript loss in bladder cancer constitutes an independent molecular predictor of TaT1 patients post-treatment relapse and progression.
Autorzy :
Papadimitriou MA; Department of Biochemistry and Molecular Biology, Faculty of Biology, National and Kapodostrian University of Athens, Panepistimiopolis, 157 01, Athens, Greece.
Avgeris M; Department of Biochemistry and Molecular Biology, Faculty of Biology, National and Kapodostrian University of Athens, Panepistimiopolis, 157 01, Athens, Greece.
Levis PK; First Department of Urology, 'Laiko' General Hospital, Medical School, National and Kapodostrian University of Athens, Agiou Thoma 17, 11527, Athens, Greece.
Tokas T; First Department of Urology, 'Laiko' General Hospital, Medical School, National and Kapodostrian University of Athens, Agiou Thoma 17, 11527, Athens, Greece.
Stravodimos K; First Department of Urology, 'Laiko' General Hospital, Medical School, National and Kapodostrian University of Athens, Agiou Thoma 17, 11527, Athens, Greece.
Scorilas A; Department of Biochemistry and Molecular Biology, Faculty of Biology, National and Kapodostrian University of Athens, Panepistimiopolis, 157 01, Athens, Greece. .
Pokaż więcej
Źródło :
Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2019 Dec; Vol. 145 (12), pp. 3075-3087. Date of Electronic Publication: 2019 Oct 08.
Typ publikacji :
Journal Article
MeSH Terms :
Amino Acid Transport Systems, Neutral/*metabolism
Neoplasm Recurrence, Local/*metabolism
Transcription Factors/*metabolism
Tumor Suppressor Proteins/*metabolism
Urinary Bladder Neoplasms/*metabolism
Aged ; Biomarkers, Tumor/metabolism ; Chronic Disease ; Disease Progression ; Female ; Humans ; Kaplan-Meier Estimate ; Male ; Neoplasm Invasiveness/pathology ; Neoplasm Recurrence, Local/pathology ; Prognosis ; Recurrence ; Urinary Bladder Neoplasms/pathology
Czasopismo naukowe
Tytuł :
The prognostic factors of recurrence and survival in female patients with lung adenocarcinoma and breast cancer.
Autorzy :
Chen YY; Graduate Institute of Medical Science, National Defense Medical Center, Taipei, Taiwan, ROC.; Division of Thoracic Surgery, Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, 325, Section 2, Cheng-Kung Road, Taipei, 114, Taiwan, ROC.
Huang YJ; Division of Thoracic Surgery, Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, 325, Section 2, Cheng-Kung Road, Taipei, 114, Taiwan, ROC.
Huang HK; Division of Thoracic Surgery, Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, 325, Section 2, Cheng-Kung Road, Taipei, 114, Taiwan, ROC.
Chang H; Division of Thoracic Surgery, Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, 325, Section 2, Cheng-Kung Road, Taipei, 114, Taiwan, ROC.
Lee SC; Division of Thoracic Surgery, Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, 325, Section 2, Cheng-Kung Road, Taipei, 114, Taiwan, ROC.
Shieh YS; Graduate Institute of Medical Science, National Defense Medical Center, Taipei, Taiwan, ROC.; Department of Dentistry, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROC.
Huang TW; Graduate Institute of Medical Science, National Defense Medical Center, Taipei, Taiwan, ROC. .; Division of Thoracic Surgery, Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, 325, Section 2, Cheng-Kung Road, Taipei, 114, Taiwan, ROC. .
Pokaż więcej
Źródło :
Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2020 May; Vol. 146 (5), pp. 1299-1306. Date of Electronic Publication: 2020 Feb 27.
Typ publikacji :
Journal Article
MeSH Terms :
Adenocarcinoma of Lung/*diagnosis
Breast Neoplasms/*diagnosis
Lung Neoplasms/*diagnosis
Neoplasm Recurrence, Local/*diagnosis
Neoplasms, Second Primary/*diagnosis
Adenocarcinoma of Lung/epidemiology ; Adenocarcinoma of Lung/metabolism ; Breast Neoplasms/epidemiology ; Breast Neoplasms/metabolism ; Female ; Humans ; Kaplan-Meier Estimate ; Lung Neoplasms/epidemiology ; Lung Neoplasms/metabolism ; Neoplasm Recurrence, Local/epidemiology ; Neoplasm Recurrence, Local/metabolism ; Neoplasms, Second Primary/epidemiology ; Prognosis ; Propensity Score ; Receptor, ErbB-2/metabolism ; Registries ; Retrospective Studies ; Risk ; Taiwan/epidemiology
Czasopismo naukowe
Tytuł :
[Nephroureterectomy for upper tract urothelial carcinoma : Effectiveness of single-dose intravesical chemotherapy].
Autorzy :
Spek A; Klinikum der Universität München Großhadern, München, Deutschland. .; für Urologie, Martin-Buber-Str. 10, 14163, Berlin, Deutschland. .
Pokaż więcej
Transliterated Title :
Nephroureterektomie beim Urothelkarzinom des oberen Harntraktes : Wirksamkeit einer Einzeldosis der intravesikalen Chemotherapie.
Źródło :
Der Urologe. Ausg. A [Urologe A] 2020 Apr; Vol. 59 (4), pp. 480-483.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Antineoplastic Agents/*administration & dosage
Carcinoma, Transitional Cell/*surgery
Neoplasm Recurrence, Local/*prevention & control
Nephroureterectomy/*methods
Ureteral Neoplasms/*surgery
Urologic Neoplasms/*drug therapy
Urologic Neoplasms/*surgery
Administration, Intravesical ; Humans ; Neoplasm Recurrence, Local/pathology ; Nephrectomy/methods ; Retrospective Studies ; Urologic Neoplasms/pathology
Czasopismo naukowe
Tytuł :
Radiomics approach for prediction of recurrence in skull base meningiomas.
Autorzy :
Zhang Y; Department of Radiological Sciences, University of California, Irvine, CA, USA.
Chen JH; Department of Radiological Sciences, University of California, Irvine, CA, USA.; Department of Radiology, E-DA Hospital, E-DA Cancer Hospital, I-Shou University, Kaohsiung, Taiwan.
Chen TY; Department of Medical Imaging, Chi-Mei Medical Center, Tainan, Taiwan.; Graduate Institute of Medical Sciences, Chang Jung Christian University, Tainan, Taiwan.
Lim SW; Department of Neurosurgery, Chi-Mei Medical Center, Chiali, Tainan, Taiwan.; Department of Nursing, Min-Hwei College of Health Care, Management, Tainan, Taiwan.
Wu TC; Department of Medical Imaging, Chi-Mei Medical Center, Tainan, Taiwan.; Graduate Institute of Medical Sciences, Chang Jung Christian University, Tainan, Taiwan.; Department of Biomedical Imaging and Radiological Sciences, National Yang-Ming University, Taipei, Taiwan.
Kuo YT; Department of Medical Imaging, Chi-Mei Medical Center, Tainan, Taiwan.; Department of of Medical Imaging, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
Ko CC; Department of Medical Imaging, Chi-Mei Medical Center, Tainan, Taiwan. .; Center of General Education, Chia Nan University of Pharmacy and Science, Tainan, Taiwan. .
Su MY; Department of Radiological Sciences, University of California, Irvine, CA, USA.
Pokaż więcej
Źródło :
Neuroradiology [Neuroradiology] 2019 Dec; Vol. 61 (12), pp. 1355-1364. Date of Electronic Publication: 2019 Jul 19.
Typ publikacji :
Journal Article
MeSH Terms :
Magnetic Resonance Imaging/*methods
Meningioma/*diagnostic imaging
Neoplasm Recurrence, Local/*diagnostic imaging
Skull Base Neoplasms/*diagnostic imaging
Adult ; Algorithms ; Contrast Media ; Decision Trees ; Disease Progression ; Female ; Humans ; Image Interpretation, Computer-Assisted ; Male ; Meningioma/pathology ; Meningioma/surgery ; Middle Aged ; Neoplasm Grading ; Neoplasm Recurrence, Local/pathology ; Neoplasm Recurrence, Local/surgery ; Predictive Value of Tests ; Retrospective Studies ; Skull Base Neoplasms/pathology ; Skull Base Neoplasms/surgery
Czasopismo naukowe
Tytuł :
Polypharmacy as a prognostic factor in older patients with advanced non-small-cell lung cancer treated with anti-PD-1/PD-L1 antibody-based immunotherapy.
Autorzy :
Hakozaki T; Department of Thoracic Oncology and Respiratory Medicine, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, 3-18-22 Honkomagome, Bunkyo, Tokyo, 113-8677, Japan.
Hosomi Y; Department of Thoracic Oncology and Respiratory Medicine, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, 3-18-22 Honkomagome, Bunkyo, Tokyo, 113-8677, Japan. .
Shimizu A; Department of Thoracic Oncology and Respiratory Medicine, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, 3-18-22 Honkomagome, Bunkyo, Tokyo, 113-8677, Japan.
Kitadai R; Department of Thoracic Oncology and Respiratory Medicine, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, 3-18-22 Honkomagome, Bunkyo, Tokyo, 113-8677, Japan.
Mirokuji K; Department of Thoracic Oncology and Respiratory Medicine, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, 3-18-22 Honkomagome, Bunkyo, Tokyo, 113-8677, Japan.
Okuma Y; Department of Thoracic Oncology, National Cancer Center Hospital, 5-1-1Tsukiji, Chuo, Tokyo, 105-0045, Japan.
Pokaż więcej
Źródło :
Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2020 Oct; Vol. 146 (10), pp. 2659-2668. Date of Electronic Publication: 2020 May 27.
Typ publikacji :
Journal Article
MeSH Terms :
Antibodies, Monoclonal, Humanized/*therapeutic use
Antineoplastic Agents, Immunological/*therapeutic use
B7-H1 Antigen/*antagonists & inhibitors
Carcinoma, Non-Small-Cell Lung/*drug therapy
Lung Neoplasms/*drug therapy
Programmed Cell Death 1 Receptor/*antagonists & inhibitors
Age Factors ; Aged ; Aged, 80 and over ; Antibodies, Monoclonal, Humanized/adverse effects ; Antineoplastic Agents, Immunological/adverse effects ; B7-H1 Antigen/immunology ; Carcinoma, Non-Small-Cell Lung/immunology ; Female ; Humans ; Inappropriate Prescribing ; Lung Neoplasms/immunology ; Male ; Neoplasm Recurrence, Local/drug therapy ; Neoplasm Recurrence, Local/immunology ; Nivolumab/adverse effects ; Nivolumab/therapeutic use ; Polypharmacy ; Prognosis ; Programmed Cell Death 1 Receptor/immunology ; Progression-Free Survival ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Outcome in serous ovarian cancer is not associated with LATS expression.
Autorzy :
Montavon C; Gynecological Cancer Center, Hospital for Women, University Hospital Basel and University of Basel, 4021, Basel, Switzerland.
Stricker GR; Gynecological Cancer Center, Hospital for Women, University Hospital Basel and University of Basel, 4021, Basel, Switzerland.
Schoetzau A; Ovarian Cancer Research, Department of Biomedicine, University Hospital Basel and University of Basel, 4031, Basel, Switzerland.
Heinzelmann-Schwarz V; Gynecological Cancer Center, Hospital for Women, University Hospital Basel and University of Basel, 4021, Basel, Switzerland.; Ovarian Cancer Research, Department of Biomedicine, University Hospital Basel and University of Basel, 4031, Basel, Switzerland.
Jacob F; Ovarian Cancer Research, Department of Biomedicine, University Hospital Basel and University of Basel, 4031, Basel, Switzerland.; Glyco-Ooncology, Ovarian Cancer Research, Department of Biomedicine, University Hospital Basel and University of Basel, 4031, Basel, Switzerland.
Fedier A; Ovarian Cancer Research, Department of Biomedicine, University Hospital Basel and University of Basel, 4031, Basel, Switzerland. .
Pokaż więcej
Źródło :
Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2019 Nov; Vol. 145 (11), pp. 2737-2749. Date of Electronic Publication: 2019 Oct 04.
Typ publikacji :
Journal Article
MeSH Terms :
Biomarkers, Tumor/*metabolism
Cystadenocarcinoma, Serous/*mortality
Neoplasm Recurrence, Local/*mortality
Ovarian Neoplasms/*mortality
Protein-Serine-Threonine Kinases/*metabolism
Tumor Suppressor Proteins/*metabolism
Adenocarcinoma, Clear Cell/metabolism ; Adenocarcinoma, Clear Cell/mortality ; Adenocarcinoma, Clear Cell/pathology ; Adenocarcinoma, Mucinous/metabolism ; Adenocarcinoma, Mucinous/mortality ; Adenocarcinoma, Mucinous/pathology ; Cell Proliferation ; Cohort Studies ; Cystadenocarcinoma, Serous/metabolism ; Cystadenocarcinoma, Serous/pathology ; Endometrial Neoplasms/metabolism ; Endometrial Neoplasms/mortality ; Endometrial Neoplasms/pathology ; Female ; Follow-Up Studies ; Gene Expression Regulation, Neoplastic ; Humans ; Neoplasm Recurrence, Local/metabolism ; Neoplasm Recurrence, Local/pathology ; Ovarian Neoplasms/metabolism ; Ovarian Neoplasms/pathology ; Prognosis ; Survival Rate ; Tumor Cells, Cultured
Czasopismo naukowe
Tytuł :
Association between lymphovascular invasion and oncologic outcomes among upper urinary tract urothelial carcinoma patients who underwent radical nephroureterectomy.
Autorzy :
Song SH; Department of Urology, Seoul National University Bundang Hospital, 300, Gumi-dong, Bundang-gu, Seongnam-si, Kyunggi-do, 463-707, Korea.
Ye CH; Department of Urology, Seoul National University Bundang Hospital, 300, Gumi-dong, Bundang-gu, Seongnam-si, Kyunggi-do, 463-707, Korea.
Lee S; Department of Urology, Seoul National University Bundang Hospital, 300, Gumi-dong, Bundang-gu, Seongnam-si, Kyunggi-do, 463-707, Korea.
Hong SK; Department of Urology, Seoul National University Bundang Hospital, 300, Gumi-dong, Bundang-gu, Seongnam-si, Kyunggi-do, 463-707, Korea.; Department of Urology, Seoul National University College of Medicine, Seoul, Korea.
Byun SS; Department of Urology, Seoul National University Bundang Hospital, 300, Gumi-dong, Bundang-gu, Seongnam-si, Kyunggi-do, 463-707, Korea.; Department of Urology, Seoul National University College of Medicine, Seoul, Korea.
Lee SE; Department of Urology, Seoul National University Bundang Hospital, 300, Gumi-dong, Bundang-gu, Seongnam-si, Kyunggi-do, 463-707, Korea.
Oh JJ; Department of Urology, Seoul National University Bundang Hospital, 300, Gumi-dong, Bundang-gu, Seongnam-si, Kyunggi-do, 463-707, Korea. .; Department of Urology, Seoul National University College of Medicine, Seoul, Korea. .
Pokaż więcej
Źródło :
Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2019 Nov; Vol. 145 (11), pp. 2863-2870. Date of Electronic Publication: 2019 Sep 09.
Typ publikacji :
Clinical Trial; Journal Article
MeSH Terms :
Lymph Nodes/*pathology
Lymphatic Vessels/*pathology
Neoplasm Recurrence, Local/*mortality
Nephroureterectomy/*mortality
Urologic Neoplasms/*mortality
Aged ; Female ; Follow-Up Studies ; Humans ; Lymphatic Metastasis ; Male ; Neoplasm Invasiveness ; Neoplasm Recurrence, Local/pathology ; Neoplasm Recurrence, Local/surgery ; Prognosis ; Retrospective Studies ; Survival Rate ; Urologic Neoplasms/pathology ; Urologic Neoplasms/surgery
Czasopismo naukowe
Tytuł :
[Malignant epithelioid angiomyolipoma of the kidney: a rare case].
Autorzy :
Vogt K; Abteilung für Urologie, Asklepios Klinik Barmbek, Rübenkamp 220, 22291, Hamburg, Deutschland. .
Gross AJ
Feyerabend B
Netsch C
Pokaż więcej
Transliterated Title :
Malignes epitheloides Angiomyolipom der Niere: ein seltener Fall.
Źródło :
Der Urologe. Ausg. A [Urologe A] 2020 Nov; Vol. 59 (11), pp. 1377-1380.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Angiomyolipoma*/diagnostic imaging
Angiomyolipoma*/surgery
Kidney Neoplasms*/diagnostic imaging
Kidney Neoplasms*/surgery
Germany ; Humans ; Middle Aged ; Neoplasm Recurrence, Local ; Nephrectomy
Czasopismo naukowe
Tytuł :
[Surgical treatment of intracaval tumor relapse after radical tumor nephrectomy in locally advanced renal cell carcinoma].
Autorzy :
von Zehmen T; Klinik für Urologie, Uro-Onkologie, roboter-assistierte und spezielle urologische Chirurgie, Uniklinik Köln, Kerpener Str. 62, 50937, Köln, Deutschland.
Eich C; Klinik für Urologie, Uro-Onkologie, roboter-assistierte und spezielle urologische Chirurgie, Uniklinik Köln, Kerpener Str. 62, 50937, Köln, Deutschland.
Fries J; Klinik für Urologie, Uro-Onkologie, roboter-assistierte und spezielle urologische Chirurgie, Uniklinik Köln, Kerpener Str. 62, 50937, Köln, Deutschland.
von Brandenstein M; Klinik für Urologie, Uro-Onkologie, roboter-assistierte und spezielle urologische Chirurgie, Uniklinik Köln, Kerpener Str. 62, 50937, Köln, Deutschland.
Pfister D; Klinik für Urologie, Uro-Onkologie, roboter-assistierte und spezielle urologische Chirurgie, Uniklinik Köln, Kerpener Str. 62, 50937, Köln, Deutschland.
Heidenreich A; Klinik für Urologie, Uro-Onkologie, roboter-assistierte und spezielle urologische Chirurgie, Uniklinik Köln, Kerpener Str. 62, 50937, Köln, Deutschland. .
Pokaż więcej
Transliterated Title :
Chirurgische Therapie des intrakavalen Tumorrezidivs nach radikaler Tumornephrektomie lokal fortgeschrittener Nierenzellkarzinome.
Źródło :
Der Urologe. Ausg. A [Urologe A] 2020 Oct; Vol. 59 (10), pp. 1217-1224.
Typ publikacji :
Journal Article
MeSH Terms :
Carcinoma, Renal Cell*/surgery
Kidney Neoplasms*/surgery
Aged ; Aged, 80 and over ; Humans ; Neoplasm Recurrence, Local/surgery ; Nephrectomy ; Retrospective Studies ; Vena Cava, Inferior/diagnostic imaging ; Vena Cava, Inferior/surgery
Czasopismo naukowe
Tytuł :
Mild COVID-19 symptoms despite treatment with teriflunomide and high-dose methylprednisolone due to multiple sclerosis relapse.
Autorzy :
Möhn N; Department of Neurology, Hannover Medical School, Hannover, Germany.
Saker F; Department of Neurology, Hannover Medical School, Hannover, Germany.
Bonda V; Department of Neurology, Hannover Medical School, Hannover, Germany.
Respondek G; Department of Neurology, Hannover Medical School, Hannover, Germany.
Bachmann M; Department of Rheumatology and Immunology, Hannover Medical School, Hannover, Germany.
Stoll M; Department of Rheumatology and Immunology, Hannover Medical School, Hannover, Germany.
Wattjes MP; Department of Diagnostic and Interventional Neuroradiology, Hannover Medical School, Hannover, Germany.
Stangel M; Department of Neurology, Hannover Medical School, Hannover, Germany.
Skripuletz T; Department of Neurology, Hannover Medical School, Hannover, Germany. .
Pokaż więcej
Źródło :
Journal of neurology [J Neurol] 2020 Oct; Vol. 267 (10), pp. 2803-2805. Date of Electronic Publication: 2020 May 28.
Typ publikacji :
Case Reports; Letter
MeSH Terms :
Anti-Inflammatory Agents/*therapeutic use
Coronavirus Infections/*complications
Methylprednisolone/*therapeutic use
Multiple Sclerosis, Relapsing-Remitting/*complications
Multiple Sclerosis, Relapsing-Remitting/*drug therapy
Pneumonia, Viral/*complications
Adult ; Betacoronavirus ; Crotonates/therapeutic use ; Humans ; Male ; Pandemics ; Recurrence ; Toluidines/therapeutic use
SCR Disease Name :
COVID-19
Raport
Tytuł :
Predicting the risk of locoregional recurrence after early breast cancer: an external validation of the Dutch INFLUENCE-nomogram with clinical cancer registry data from Germany.
Autorzy :
Voelkel V; Institute for Quality Control and Health Services Research, Tumor Center Regensburg/University of Regensburg, Regensburg, Germany. .; Department of Health Technology and Services Research, Technical Medical Centre, University of Twente, Enschede, The Netherlands. .
Draeger T; Institute for Quality Control and Health Services Research, Tumor Center Regensburg/University of Regensburg, Regensburg, Germany.; Department of Health Technology and Services Research, Technical Medical Centre, University of Twente, Enschede, The Netherlands.
Groothuis-Oudshoorn CGM; Department of Health Technology and Services Research, Technical Medical Centre, University of Twente, Enschede, The Netherlands.
de Munck L; Department of Research, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.
Hueting T; Evidencio, Medical Decision Support, Haaksbergen, The Netherlands.
Gerken M; Institute for Quality Control and Health Services Research, Tumor Center Regensburg/University of Regensburg, Regensburg, Germany.
Klinkhammer-Schalke M; Institute for Quality Control and Health Services Research, Tumor Center Regensburg/University of Regensburg, Regensburg, Germany.
Lavric M; Department of Health Technology and Services Research, Technical Medical Centre, University of Twente, Enschede, The Netherlands.
Siesling S; Department of Health Technology and Services Research, Technical Medical Centre, University of Twente, Enschede, The Netherlands.; Department of Research, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.
Pokaż więcej
Źródło :
Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2019 Jul; Vol. 145 (7), pp. 1823-1833. Date of Electronic Publication: 2019 Mar 29.
Typ publikacji :
Journal Article
MeSH Terms :
Nomograms*
Breast Neoplasms/*epidemiology
Neoplasm Recurrence, Local/*enzymology
Aged ; Breast Neoplasms/pathology ; Breast Neoplasms/surgery ; Cohort Studies ; Female ; Germany/epidemiology ; Humans ; Middle Aged ; Neoplasm Recurrence, Local/diagnosis ; Neoplasm Recurrence, Local/pathology ; Netherlands/epidemiology ; Registries ; Reproducibility of Results
Czasopismo naukowe
Tytuł :
Selected protein expression in a new prognostic model for patients with non-muscle-invasive bladder cancer.
Autorzy :
Semeniuk-Wojtaś A; Oncology Department, Military Institute of Medicine, 128 Szaserów St., 04-141, Warsaw, Poland. .
Lubas A; Internal Diseases, Nephrology and Dialysis Department, Military Institute of Medicine, 128 Szaserów St., 04-141, Warsaw, Poland.
Cierniak S; Patomorphology Department, Military Institute of Medicine, 128 Szaserów St., 04-141, Warsaw, Poland.
Brzóskowska U; Patomorphology Department, Military Institute of Medicine, 128 Szaserów St., 04-141, Warsaw, Poland.
Syryło T; General, Functional and Oncological Urology Department, Military Institute of Medicine, 128 Szaserów St., 04-141, Warsaw, Poland.
Zieliński H; General, Functional and Oncological Urology Department, Military Institute of Medicine, 128 Szaserów St., 04-141, Warsaw, Poland.
Stec R; Oncology Department, Medical University of Warsaw, 19/25 Stępińska St., 00-739, Warsaw, Poland.
Pokaż więcej
Źródło :
Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2020 Aug; Vol. 146 (8), pp. 2099-2108. Date of Electronic Publication: 2020 Apr 01.
Typ publikacji :
Journal Article
MeSH Terms :
Models, Statistical*
Ki-67 Antigen/*biosynthesis
Survivin/*biosynthesis
Tumor Suppressor Protein p53/*biosynthesis
Urinary Bladder Neoplasms/*metabolism
Decision Support Systems, Clinical ; Disease-Free Survival ; Female ; Humans ; Immunohistochemistry ; Male ; Neoplasm Invasiveness ; Neoplasm Recurrence, Local/metabolism ; Neoplasm Recurrence, Local/pathology ; Neoplasm Staging ; Prognosis ; Proportional Hazards Models ; Retrospective Studies ; Urinary Bladder Neoplasms/pathology ; Urinary Bladder Neoplasms/surgery
Czasopismo naukowe
Tytuł :
[Management of complications following tumor endoprosthetic replacement].
Autorzy :
Fritzsche H; UniversitätsCentrum für Orthopädie & Unfallchirurgie, Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden, Fetscherstraße 74, 01307, Dresden, Deutschland. .
Hofbauer C; UniversitätsCentrum für Orthopädie & Unfallchirurgie, Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden, Fetscherstraße 74, 01307, Dresden, Deutschland.
Winkler D; UniversitätsCentrum für Orthopädie & Unfallchirurgie, Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden, Fetscherstraße 74, 01307, Dresden, Deutschland.
Günther KP; UniversitätsCentrum für Orthopädie & Unfallchirurgie, Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden, Fetscherstraße 74, 01307, Dresden, Deutschland.
Goronzy J; UniversitätsCentrum für Orthopädie & Unfallchirurgie, Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden, Fetscherstraße 74, 01307, Dresden, Deutschland.
Lützner J; UniversitätsCentrum für Orthopädie & Unfallchirurgie, Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden, Fetscherstraße 74, 01307, Dresden, Deutschland.
Kisel W; UniversitätsCentrum für Orthopädie & Unfallchirurgie, Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden, Fetscherstraße 74, 01307, Dresden, Deutschland.
Schaser KD; UniversitätsCentrum für Orthopädie & Unfallchirurgie, Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden, Fetscherstraße 74, 01307, Dresden, Deutschland.
Pokaż więcej
Transliterated Title :
Komplikationsmanagement nach Tumorendoprothesen.
Źródło :
Der Orthopade [Orthopade] 2019 Jul; Vol. 48 (7), pp. 588-597.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Bone Neoplasms*/complications
Neoplasm Recurrence, Local*/complications
Femur ; Humans ; Prosthesis Failure ; Reoperation/instrumentation ; Reoperation/methods ; Treatment Outcome
Czasopismo naukowe
Tytuł :
PPARγ activation by pioglitazone does not suppress cravings for alcohol, and is associated with a risk of myopathy in treatment seeking alcohol dependent patients: a randomized controlled proof of principle study.
Autorzy :
Schwandt ML; Office of the Clinical Director, National Institute on Alcohol Abuse and Alcoholism, 10 Center Drive, CRC 1-5330, Bethesda, MD, 20892, USA. .
Diazgranados N; Office of the Clinical Director, National Institute on Alcohol Abuse and Alcoholism, 10 Center Drive, CRC 1-5330, Bethesda, MD, 20892, USA.
Umhau JC; Center for Drug Evaluation and Research (CDER), United States Food and Drug Administration, Washington, DC, USA.
Kwako LE; Division of Treatment and Recovery Research, National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD, USA.
George DT; Office of the Clinical Director, National Institute on Alcohol Abuse and Alcoholism, 10 Center Drive, CRC 1-5330, Bethesda, MD, 20892, USA.
Heilig M; Center for Social and Affective Neuroscience, Linköping University, Linköping, Sweden.
Pokaż więcej
Źródło :
Psychopharmacology [Psychopharmacology (Berl)] 2020 Aug; Vol. 237 (8), pp. 2367-2380. Date of Electronic Publication: 2020 May 22.
Typ publikacji :
Journal Article; Randomized Controlled Trial
MeSH Terms :
Alcoholism/*metabolism
Craving/*drug effects
Muscular Diseases/*chemically induced
Muscular Diseases/*metabolism
PPAR gamma/*metabolism
Pioglitazone/*therapeutic use
Adult ; Alcoholism/drug therapy ; Animals ; Craving/physiology ; Double-Blind Method ; Female ; Humans ; Hypoglycemic Agents/adverse effects ; Hypoglycemic Agents/therapeutic use ; Imagination/drug effects ; Imagination/physiology ; Lipopolysaccharides/adverse effects ; Male ; Middle Aged ; Muscular Diseases/diagnosis ; Pioglitazone/adverse effects ; Proof of Concept Study ; Recurrence ; Young Adult
Czasopismo naukowe
Tytuł :
Ecological momentary assessment of temptations and lapses in non-daily smokers.
Autorzy :
Shiffman S; Department of Psychology, University of Pittsburgh, 130 N. Bellefield Ave, Suite 510, Pittsburgh, PA, 15213, USA. .
Scholl SM; Department of Psychology, University of Pittsburgh, 130 N. Bellefield Ave, Suite 510, Pittsburgh, PA, 15213, USA.
Mao J; Department of Biostatistics, University of Pittsburgh, Pittsburgh, PA, USA.
Ferguson SG; College of Health & Medicine, University of Tasmania, Hobart, TAS, Australia.
Hedeker D; Department of Public Health Sciences, University of Chicago, Chicago, IL, USA.
Tindle HA; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.; Geriatric Research Education and Clinical Centers (GRECC), Veterans Affairs Tennessee Valley Healthcare System, Nashville, TN, USA.
Pokaż więcej
Źródło :
Psychopharmacology [Psychopharmacology (Berl)] 2020 Aug; Vol. 237 (8), pp. 2353-2365. Date of Electronic Publication: 2020 May 12.
Typ publikacji :
Journal Article; Randomized Controlled Trial
MeSH Terms :
Ecological Momentary Assessment*
Cigarette Smoking/*psychology
Cigarette Smoking/*therapy
Smokers/*psychology
Smoking Cessation/*psychology
Adaptation, Psychological/drug effects ; Adaptation, Psychological/physiology ; Adult ; Behavior Therapy/methods ; Craving/drug effects ; Craving/physiology ; Female ; Humans ; Male ; Middle Aged ; Motivation/drug effects ; Motivation/physiology ; Nicotine Chewing Gum ; Recurrence ; Smoking Cessation/methods
Czasopismo naukowe
Tytuł :
Older age and comorbidity in breast cancer: is RT alone the new therapeutic frontier?
Autorzy :
La Rocca E; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Radiation Oncology 1, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.
Meneghini E; Analytical Epidemiology and Health Impact Unit, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.
Lozza L; Radiation Oncology 1, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.
Fiorentino A; Department of Radiation Oncology, Regional General Hospital 'F Miulli', Acquaviva delle Fonti, BA, Italy.
Vitullo A; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Radiation Oncology 1, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.
Giandini C; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Radiation Oncology 1, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.
Bonfantini F; Medical Physics Unit, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.
Di Cosimo S; Department of Applied Research and Technological Development DRAST, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.
Gennaro M; Breast Surgery Unit, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.
Sant M; Analytical Epidemiology and Health Impact Unit, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.
Pignoli E; Medical Physics Unit, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.
Valdagni R; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Radiation Oncology 1 and Prostate Cancer Program, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.
De Santis MC; Radiation Oncology 1, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy. .
Pokaż więcej
Źródło :
Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2020 Jul; Vol. 146 (7), pp. 1791-1800. Date of Electronic Publication: 2020 May 13.
Typ publikacji :
Journal Article
MeSH Terms :
Geriatric Assessment*
Breast Neoplasms/*epidemiology
Age Factors ; Aged ; Aged, 80 and over ; Antineoplastic Agents, Hormonal/administration & dosage ; Antineoplastic Agents, Hormonal/adverse effects ; Antineoplastic Agents, Hormonal/therapeutic use ; Breast Neoplasms/diagnosis ; Breast Neoplasms/mortality ; Breast Neoplasms/radiotherapy ; Combined Modality Therapy ; Comorbidity ; Female ; Humans ; Neoplasm Metastasis ; Neoplasm Staging ; Patient Compliance ; Prognosis ; Radiation Dose Hypofractionation ; Radiotherapy, Adjuvant ; Recurrence ; Treatment Outcome
Czasopismo naukowe
Tytuł :
[Checkpoint inhibitors in Hodgkin lymphoma].
Autorzy :
Sasse S; Medizinische Klinik I, Uniklinik Köln, Kerpener Str. 62, 50937, Köln, Deutschland.; Deutsche Hodgkin Studiengruppe (GHSG), Uniklinik Köln, Kerpener Str. 62, 50937, Köln, Deutschland.
Momotow J; Medizinische Klinik I, Uniklinik Köln, Kerpener Str. 62, 50937, Köln, Deutschland.; Deutsche Hodgkin Studiengruppe (GHSG), Uniklinik Köln, Kerpener Str. 62, 50937, Köln, Deutschland.
Engert A; Medizinische Klinik I, Uniklinik Köln, Kerpener Str. 62, 50937, Köln, Deutschland. .; Deutsche Hodgkin Studiengruppe (GHSG), Uniklinik Köln, Kerpener Str. 62, 50937, Köln, Deutschland. .
Pokaż więcej
Transliterated Title :
Checkpoint-Inhibitoren bei Hodgkin-Lymphom.
Źródło :
Der Internist [Internist (Berl)] 2020 Jul; Vol. 61 (7), pp. 660-668.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Antibodies, Monoclonal/*therapeutic use
Antineoplastic Agents, Immunological/*therapeutic use
Doxorubicin/*therapeutic use
Hodgkin Disease/*drug therapy
Nivolumab/*therapeutic use
Programmed Cell Death 1 Receptor/*antagonists & inhibitors
Humans ; Immunotherapy/methods ; Neoplasm Recurrence, Local ; Tumor Microenvironment
Czasopismo naukowe
Tytuł :
[Immuno-oncological therapeutic options in high-risk non-muscle invasive bladder cancer].
Autorzy :
Kramer MW; Klinik für Urologie, Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Lübeck, Deutschland.
Gakis G; Klinik und Poliklinik für Urologie und Kinderurologie, Universitätsklinikum Würzburg, Oberdürrbacher Straße 6, 97080, Würzburg, Deutschland. .
Pokaż więcej
Transliterated Title :
Immunonkologische Therapieoptionen des nicht-muskelinvasiven Urothelkarzinoms.
Źródło :
Der Urologe. Ausg. A [Urologe A] 2020 Jul; Vol. 59 (7), pp. 784-789.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Immunotherapy*
Adjuvants, Immunologic/*therapeutic use
BCG Vaccine/*therapeutic use
Programmed Cell Death 1 Receptor/*therapeutic use
Urinary Bladder Neoplasms/*therapy
Administration, Intravesical ; Cystectomy ; Humans ; Medical Oncology ; Neoplasm Invasiveness ; Neoplasm Recurrence, Local ; Treatment Outcome ; Urinary Bladder Neoplasms/immunology
Czasopismo naukowe
Tytuł :
Impact of successful local ablative bridging therapy prior to liver transplantation on long-term survival in patients with hepatocellular carcinoma in cirrhosis.
Autorzy :
Bauschke A; Department of General, Visceral and Vascular Surgery, University Hospital Jena, Erlanger Allee 101, 07740, Jena, Germany. .
Altendorf-Hofmann A; Department of General, Visceral and Vascular Surgery, University Hospital Jena, Erlanger Allee 101, 07740, Jena, Germany.
Ardelt M; Department of General, Visceral and Vascular Surgery, University Hospital Jena, Erlanger Allee 101, 07740, Jena, Germany.
Kissler H; Department of General, Visceral and Vascular Surgery, University Hospital Jena, Erlanger Allee 101, 07740, Jena, Germany.
Tautenhahn HM; Department of General, Visceral and Vascular Surgery, University Hospital Jena, Erlanger Allee 101, 07740, Jena, Germany.
Settmacher U; Department of General, Visceral and Vascular Surgery, University Hospital Jena, Erlanger Allee 101, 07740, Jena, Germany.
Pokaż więcej
Źródło :
Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2020 Jul; Vol. 146 (7), pp. 1819-1827. Date of Electronic Publication: 2020 Apr 30.
Typ publikacji :
Journal Article
MeSH Terms :
Ablation Techniques*/methods
Carcinoma, Hepatocellular/*mortality
Carcinoma, Hepatocellular/*therapy
Liver Neoplasms/*mortality
Liver Neoplasms/*therapy
Adult ; Aged ; Biomarkers, Tumor ; Carcinoma, Hepatocellular/diagnosis ; Combined Modality Therapy ; Female ; Humans ; Liver Neoplasms/diagnosis ; Liver Transplantation ; Magnetic Resonance Imaging ; Male ; Middle Aged ; Prognosis ; Recurrence ; Tomography, X-Ray Computed ; Treatment Outcome
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies